首页行业分类金融证券证券2023-03-21-国联证券-药明康德-业绩持续高增长,一体化优势凸显
PDF

2023-03-21-国联证券-药明康德-业绩持续高增长,一体化优势凸显

饺**娘3页386.74K

下载文档
/3
全屏查看
2023-03-21-国联证券-药明康德-业绩持续高增长,一体化优势凸显
还有 3 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 3 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
国联证券公司报告|年报点评2021A2022A2023E2024E2025E2021A2022A2023E2024E2025E8238.777,95.7412,9373719,754.1129,5484322.902.3939354.7841,963.3351289.8762.153.505,440.987.095.557,875.7814,59228246772228,2312432,119.7930.972.4730291290.81436.95534.0753.58200.47133.17162.78197245.905.017,479959,182.56731.59797.30974.511,058.61●2,956.722,441822,953.943,550.453,145.634439.505,795.756,8368821,985.6523,9972329,7287040,488.798.40184.82678.301,202.931,182.931,182.931,182.93.135.72-201.0219,155.08770.08500.00550.00650.005,771.797,4733111,581.0910.90332187.95480.00550.00700.001,599.751,784831,48736480.03318.21308.12314.0414734.9414,123.73132183012,312876.037.7310.,652.2511,14级1513,549.9516,737.9333141.7440.6931047.6808922.1233.7725.3325.332533551273964,6903374.0623586,97841102,615196.015.6110,6184811,1228213,524.6216.712602261483,874.120.000.000.00所得1.715.871,582.871900.352,348291,931.011,659.312,547.793,785335,135958,902619,559.9511624.2714,364318,792.1113411.093.798.9083.65101.7112,984.5914,4993615,958.891.828.121,784891,714.051,483.491,088.810.000.000000.000001,759211,499401,499.401,499401,499.402021A2022A2023E2024E2025E3,385.33,264293,2134529628817,7636519,17233224691926.2193538.50%7184%6.63%22.23%21.18%265.95336.722037647.77EBIT5684%70.02%7.87%20.13%22.99%2,955832,980.532982092,982.092,982.09EBITDA52.03%64.02%28.44%20.97%1892%25,7318926,511.5128,582.3428,5823428,582.347219%72.91%7.52%21.59%23.57%9803.7917,117.9124,9452234,482.713875746645092276,395.8437.49%37.30%3730%551273974,0623586,97841102,615192243%22.62%22.78%23.11%ROE1324%18.92%17.40%18.01%1880%ROIC3104%29.70%23.11%28.37%3202%2021A2022A2023E2024E2025E5.135.959,559.9511,8242714,3343127.46%25.89%25.83%25.55%1270.391,717.594,339.455,808.74192.12.38.08247.971.1131.83219.1523641338.18-1,70281297804,5538039593425453106.12.504.432.54.44.24,379.7410,416.9617,644.5915,5102218,237.060406067.943.0710225.50-8.000.00-7,500.007.000.001907947984.000.000.003.03394.8其他1.198.18615.06975.751,225.003.5524838.959,690297,107396,524255,7750013.015.725.6228.541,75142250.5637468514.144.700.000.0027.025.120.82.009.513.033922293.082637.75EV/EBITDA1931439.3226227390.504951636816.74979431EV/EBIT55.822419918.112.52请务必阅读报告末页的重要声明